Rodolfo Cangiano

Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated with Tumor Progression

Alessandro Sgambato, Mario Migaldi, Micaela Montanari et al. · American Journal Of Pathology · 2003 · 116 citations · Full text

Medicine, Cancer Biology, Oncology +13

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Roberta Caputo, Giuseppe Buono, Michela Piezzo et al. · Frontiers in Oncology · 2024 · 73 citations · Full text

Medicine, Oncology, Pharmacology +17

HER2-Low Status Does Not Affect Survival Outcomes of Patients with Metastatic Breast Cancer (MBC) Undergoing First-Line Treatment with Endocrine Therapy plus Palbociclib: Results of a Multicenter, Retrospective Cohort Study

Francesca Carlino, Anna Diana, Anna Ventriglia et al. · Cancers · 2022 · 36 citations · Full text

Medicine, Endocrinology, Oncology +16

Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts

Alessandro Sgambato, Andrea Camerini, Giovambattista Pani et al. · British Journal of Cancer · 2003 · 24 citations · Full text

Medicine, Cell Biology, Oncology +17

Fist-line Treatment of Advanced Biliary Ducts Carcinoma: A Randomized Phase II Study Evaluating 5-FU/LV Plus Oxaliplatin (Folfox 4) Versus 5-FU/LV (de Gramont Regimen)

Giovanni Schinzari, Ernesto Rossi, Giuseppina Mambella et al. · Anticancer Research · 2017 · 14 citations · Full text

Medicine, Oncology, Pharmacotherapy +9